Washington Trust’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-507
| Closed | -$1.54K | – | 869 |
|
|
2024
Q4 | $1.54K | Sell |
507
-150
| -23% | -$456 | ﹤0.01% | 817 |
|
|
2024
Q3 | $3.41K | Sell |
657
-973
| -60% | -$5.05K | ﹤0.01% | 771 |
|
|
2024
Q2 | $4.19K | Hold |
1,630
| – | – | ﹤0.01% | 760 |
|
|
2024
Q1 | $8.02K | Hold |
1,630
| – | – | ﹤0.01% | 687 |
|
|
2023
Q4 | $14.3K | Buy |
1,630
+500
| +44% | +$4.4K | ﹤0.01% | 602 |
|
|
2023
Q3 | $13K | Hold |
1,130
| – | – | ﹤0.01% | 594 |
|
|
2023
Q2 | $28.6K | Hold |
1,130
| – | – | ﹤0.01% | 500 |
|
|
2023
Q1 | $36.4K | Buy |
+1,130
| New | +$36.4K | ﹤0.01% | 461 |
|